Vivos Therapeutics (VVOS) Secures $1.8M Investment from V-Co Investors

Vivos Therapeutics (VVOS) has received a financial boost with V-Co Investors 3 LLC purchasing shares worth $1.8 million. This investment indicates growing interest from institutional investors in the company, which could impact Vivos' future funding and operational capabilities. Such transactions often signal confidence in the company's business model and potential growth. The financial injection may improve market perception and lead to increased stock volatility for VVOS.